Oral administration of liposomal insulin

Journal of Nanoscience and Nanotechnology

Volumn 6, Issue 9-10, 2006, Pages 2945-2949

  Tdegim I ^a   Gümüşel, Bülent ^b   Deǧim, Zelihagül ^a   Özçelikay, Tanju ^c   Tay, Aydin ^c   Güner, Şahika ^c  

^a GAZI UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Liposomal Insulin; Liposome; Mucoadhesive Agent Added Liposome; Oral Administration Insulin

Indexed keywords

BLOOD GLUCOSE LEVELS; LIPOSOMAL INSULIN; LIPOSOME; MUCOADHESIVE AGENTS; ORAL ADMINISTRATION;

BLOOD; CHOLESTEROL; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; GLUCOSE; PH EFFECTS;

INSULIN;

ANTIDIABETIC AGENT; INSULIN; LIPOSOME; NANOMATERIAL; STREPTOZOCIN;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METHODOLOGY; MICROCAPSULE; MOUSE; ORAL DRUG ADMINISTRATION; RAT; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; INSULIN; LIPOSOMES; MICE; NANOSTRUCTURES; RATS; STREPTOZOCIN; TREATMENT OUTCOME;

EID: 33750049039     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2006.416     Document Type: Conference Paper

References (27)

1. D. Nirmalendu, K. B. Mukul, and K. D. Manoj, Biochem. Int. 16, 983 (1988).
2. H. M. Patel, B. E. Ryman, FEBS Lett. 62, 60 (1976).
3. J. Axt, D. Sarrach, and J. Zippper, Pharmazie, 38, 246 (1983).
4. J. F. Noodley, Crit. Rev. Ther. Drug. Carrier. Syst. 2, 1 (1985).
5. M. Das, M. K. Sasu, and M. K. Das, Biochem. Int. 16, 983 (1988).
6. A. J. Scheen, N. Paquot, and P. J. Lefebre, Ann. Endocrinol. 49, 386 (1988).
7. R. S. Spangler, Diabetes Care. 13, 911 (1990).
8. K. B. Choudhari, B. Labhasetwar, and A. K. Dorle, J. Microencapsul. 11, 319 (1994).
9. K. Muramatsu, Y. Maitani, and T. Nagai, Biol. Pharm. Bull. 19, 1033 (1996).
10. H. Takeuchi, H. Yamamoto, T. Niwa, T. Hino, and Y. Kawashima, Pharm. Research 3, 896 (1996).
11. G. Cevc, D. Gebauer, J. Stieber, A. Scatzlein, and G. Blume, Biochim. Biophys. Acta-Biomemb. 1368, 201 (1998).
12. M. A. Longer, H. S. Ch'ng, and J. R. Robinson. J. Pharm. Sci. 74, 406 (1985).
13. C. M. Lehr, J. A. Bouwstra, J. J. Tukker, and H. E. Junginger. J. Control. Rel. 13, 51 (1990).
14. C. M. Lehr, J. A. Bouwstra, W. Kok, A. G. De Boer, J. J. Tukker, J. C. Verhoef, D. D. Breimer, and H. E. Junginger, J. Pharm. Pharmacol. 44, 402 (1992).
15. Y. Akiyama, N. Nagahara, T. Kashihara, S. Hirai, and H. Toguchi, Pharm. Res. 12, 397 (1995).
16. V. Lenaerts, P. Couvreur, L. Grislain, and P. Maincent, in Bioadhesive Drug Delivery Systems, edited by V. Lenaerts and R. Gurny, CRC Press, FL (1990), p. 93.
17. C. Pimienta, F. Chouinard, A. Labib, and V. Lenaerts, Int. J. Pharm. 80, 1 (1992).
18. H. Takeuchi, H. Yamamoto, T. Niwa, T. Hino, and Y. Kawashima, Chem. Pharm. Bull. 42, 1954 (1994).
19. H. Takeuchi, H. Yamamoto, T. Niwa, T. Hino, and Y. Kawashima, Pharm. Res. 13, 896 (1996).
20. H. Takeuchi, Y. Matsui, H. Yamamoto, and Y. Kawashima, J. Control. Rel. 86, 235 (2003).
21. H. Takeuchi, H. Yamamoto, and Y. Kawashima, Adv. Drug Del. Rev. 47, 39 (2001).
22. H. Takeuchi, Y. Matsui, H. Sugihara, H. Yamamoto, and Y. Kawashima, Int. J. Pharm. 303, 160 (2005).
23. D. J. A. Crommelin and H. Schreier, in Colloidal Drug Delivery Systems, edited by J. Kreuter, Marcel Dekker Inc., USA (1994), p. 73.
24. W. R. Perkins, S. R. Minchey, P. L. Ahl, and A. S. Janoff, Chem. Phys. Lipids. 64, 197 (1993).
25. J. G. Cornelius, V. Tchernev, K. J. Kao, and A. B. Pack, Harm. Metab. Res. 29, 271 (1997).
26. R. N. Farinas, A. E. Lopez Vinals, E. Posse, and R. D. Morero, Biochem. J. 264, 285 (1989).
27. S. Lee, H. Yoshitomi, S. Morikawa, H. Takiguchi, and T. Inoue, Biopolymers. 36, 391 (1995).